The Lupus Foundation of America announced that it has received a 3-year grant totaling over $1.5 million from the U.S. Department of Health and Human Services’ Office of Minority Health to encourage greater inclusion of Black patients in lupus clinical trials. The new grant followed 2021 funding from the Office of Minority Health that helped the Foundation establish the Improving Minority Participation and Awareness in Clinical Trials (IMPACT+) Program—which was designed to reduce barriers to clinical trial access and health-care disparities among Black women. With the new grant, the program will identify more effective communication methods to further boost interest in lupus clinical trials among Black female patients; better understand the priorities and concerns of this patient population around receiving clinical trial education; and expand participation in the Lupus Foundation of America’s Lupus Research Action Network to ultimately enhance trial enrollment. “Diversity in lupus clinical trials is not just a matter of representation but a critical factor in ensuring the efficacy and safety of treatments, which is why programs like … IMPACT+ … [are] so important. Embracing diversity in trials is imperative for advancing lupus research and improving outcomes for all,” concluded Mary Crimmings, Interim Chief Executive Officer and Senior Vice President for Marketing and Communications at the Lupus Foundation of America.